Functional and physiopathological implications of TRP channels

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 8, 2015, Pages 1772-1782

  Smani, Tarik ^a   Shapovalov, George ^b   Skryma, Roman ^b   Prevarskaya, Natalia ^b   Rosado, Juan A ^c  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b Université des Sciences et Technologies de Lille   (France)

^c UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Cancer cells; Cardiovascular disorders; Diabetes mellitus; TRP channels; Tumorigenesis

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL;

APOPTOSIS; ARRHYTHMOGENESIS; BLOOD VESSEL TONE; CALCIUM HOMEOSTASIS; CARCINOGENESIS; CELL MIGRATION; DIABETIC NEPHROPATHY; ERECTILE DYSFUNCTION; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; MECHANICAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHANNELOPATHY; COMPLICATION; DIABETES MELLITUS; GENETICS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CHANNELOPATHIES; DIABETES MELLITUS; HUMANS; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84928911195     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.04.016     Document Type: Review

References (223)

1. Montell C., Rubin G.M. Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 1989, 2:1313-1323.
2. 2+ channel in Drosophila photoreceptors. Neuron 1992, 8:643-651.
3. Montell C. Physiology, phylogeny, and functions of the TRP superfamily of cation channels. Sci. STKE 2001, 2001:re1.
4. Moiseenkova-Bell V., Wensel T.G. Functional and structural studies of TRP channels heterologously expressed in budding yeast. Adv. Exp. Med. Biol. 2011, 704:25-40.
5. Harteneck C., Klose C., Krautwurst D. Synthetic modulators of TRP channel activity. Adv. Exp. Med. Biol. 2011, 704:87-106.
6. 2+ entry. Biochim. Biophys. Acta 2009, 1793:223-230.
7. Clapham D.E. TRP channels as cellular sensors. Nature 2003, 426:517-524.
8. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007, 87:165-217.
9. Nilius B., Szallasi A. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine. Pharmacol. Rev. 2014, 66:676-814.
10. Yue Z., Xie J., Yu A.S., Stock J., Du J., Yue L. Role of TRP channels in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 2015, 308:H157-H182.
11. Beech D.J. Characteristics of transient receptor potential canonical calcium-permeable channels and their relevance to vascular physiology and disease. Circ. J. 2013, 77:570-579.
12. Gonzalez-Cobos J.C., Trebak M. TRPC channels in smooth muscle cells. Front. Biosci. (Landmark Ed.) 2010, 15:1023-1039.
13. Vennekens R. Emerging concepts for the role of TRP channels in the cardiovascular system. J. Physiol. 2011, 589:1527-1534.
14. Bergdahl A., Gomez M.F., Dreja K., Xu S.Z., Adner M., Beech D.J., Broman J., Hellstrand P., Sward K. Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca2+ entry dependent on TRPC1. Circ. Res. 2003, 93:839-847.
15. Kunichika N., Yu Y., Remillard C.V., Platoshyn O., Zhang S., Yuan J.X. Overexpression of TRPC1 enhances pulmonary vasoconstriction induced by capacitative Ca2+ entry. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L962-L969.
16. Dietrich A., Kalwa H., Gudermann T. TRPC channels in vascular cell function. Thromb. Haemost. 2010, 103:262-270.
17. Dietrich A., Kalwa H., Storch U., Mederos y Schnitzler M., Salanova B., Pinkenburg O., Dubrovska G., Essin K., Gollasch M., Birnbaumer L., Gudermann T. Pressure-induced and store-operated cation influx in vascular smooth muscle cells is independent of TRPC1. Pflugers Arch. 2007, 455:465-477.
18. Saleh S.N., Albert A.P., Peppiatt C.M., Large W.A. Angiotensin II activates two cation conductances with distinct TRPC1 and TRPC6 channel properties in rabbit mesenteric artery myocytes. J. Physiol. 2006, 577:479-495.
19. Peppiatt-Wildman C.M., Albert A.P., Saleh S.N., Large W.A. Endothelin-1 activates a Ca2+-permeable cation channel with TRPC3 and TRPC7 properties in rabbit coronary artery myocytes. J. Physiol. 2007, 580:755-764.
20. Inoue R., Okada T., Onoue H., Hara Y., Shimizu S., Naitoh S., Ito Y., Mori Y. The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel. Circ. Res. 2001, 88:325-332.
21. Jung S., Strotmann R., Schultz G., Plant T.D. TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells. Am. J. Physiol. Cell Physiol. 2002, 282:C347-C359.
22. Weissmann N., Dietrich A., Fuchs B., Kalwa H., Ay M., Dumitrascu R., Olschewski A., Storch U., Mederos y Schnitzler M., Ghofrani H.A., Schermuly R.T., Pinkenburg O., Seeger W., Grimminger F., Gudermann T. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19093-19098.
23. Sel S., Rost B.R., Yildirim A.O., Sel B., Kalwa H., Fehrenbach H., Renz H., Gudermann T., Dietrich A. Loss of classical transient receptor potential 6 channel reduces allergic airway response. Clin. Exp. Allergy 2008, 38:1548-1558.
24. Dietrich A., Mederos Y.S.M., Gollasch M., Gross V., Storch U., Dubrovska G., Obst M., Yildirim E., Salanova B., Kalwa H., Essin K., Pinkenburg O., Luft F.C., Gudermann T., Birnbaumer L. Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol. Cell. Biol. 2005, 25:6980-6989.
25. Inoue R., Jian Z., Kawarabayashi Y. Mechanosensitive TRP channels in cardiovascular pathophysiology. Pharmacol. Ther. 2009, 123:371-385.
26. Earley S. TRPA1 channels in the vasculature. Br. J. Pharmacol. 2012, 167:13-22.
27. Welsh D.G., Morielli A.D., Nelson M.T., Brayden J.E. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ. Res. 2002, 90:248-250.
28. Mathar I., Vennekens R., Meissner M., Kees F., Van der Mieren G., Camacho Londono J.E., Uhl S., Voets T., Hummel B., van den Bergh A., Herijgers P., Nilius B., Flockerzi V., Schweda F., Freichel M. Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J. Clin. Invest. 2010, 120:3267-3279.
29. Sharif-Naeini R., Folgering J.H., Bichet D., Duprat F., Lauritzen I., Arhatte M., Jodar M., Dedman A., Chatelain F.C., Schulte U., Retailleau K., Loufrani L., Patel A., Sachs F., Delmas P., Peters D.J., Honore E. Polycystin-1 and -2 dosage regulates pressure sensing. Cell 2009, 139:587-596.
30. Wamhoff B.R., Bowles D.K., Owens G.K. Excitation-transcription coupling in arterial smooth muscle. Circ. Res. 2006, 98:868-878.
31. Rodriguez-Moyano M., Diaz I., Dionisio N., Zhang X., Avila-Medina J., Calderon-Sanchez E., Trebak M., Rosado J.A., Ordonez A., Smani T. Urotensin-II promotes vascular smooth muscle cell proliferation through store operated calcium entry and EGFR transactivation. Cardiovasc. Res. 2013, 100:297-306.
32. Kumar B., Dreja K., Shah S.S., Cheong A., Xu S.Z., Sukumar P., Naylor J., Forte A., Cipollaro M., McHugh D., Kingston P.A., Heagerty A.M., Munsch C.M., Bergdahl A., Hultgardh-Nilsson A., Gomez M.F., Porter K.E., Hellstrand P., Beech D.J. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ. Res. 2006, 98:557-563.
33. Takahashi Y., Watanabe H., Murakami M., Ohba T., Radovanovic M., Ono K., Iijima T., Ito H. Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis 2007, 195:287-296.
34. Berra-Romani R., Mazzocco-Spezzia A., Pulina M.V., Golovina V.A. Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am. J. Physiol. Cell Physiol. 2008, 295:C779-C790.
35. Yu Y., Keller S.H., Remillard C.V., Safrina O., Nicholson A., Zhang S.L., Jiang W., Vangala N., Landsberg J.W., Wang J.Y., Thistlethwaite P.A., Channick R.N., Robbins I.M., Loyd J.E., Ghofrani H.A., Grimminger F., Schermuly R.T., Cahalan M.D., Rubin L.J., Yuan J.X. A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation 2009, 119:2313-2322.
36. Koenig S., Schernthaner M., Maechler H., Kappe C.O., Glasnov T.N., Hoefler G., Braune M., Wittchow E., Groschner K. A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-c arboxylate (Pyr3), prevents stent-induced arterial remodeling. J. Pharmacol. Exp. Ther. 2013, 344:33-40.
37. Schleifer H., Doleschal B., Lichtenegger M., Oppenrieder R., Derler I., Frischauf I., Glasnov T.N., Kappe C.O., Romanin C., Groschner K. Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways. Br. J. Pharmacol. 2012, 167:1712-1722.
38. Wang Y.X., Wang J., Wang C., Liu J., Shi L.P., Xu M. Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells. J. Membr. Biol. 2008, 223:151-159.
39. Martin E., Dahan D., Cardouat G., Gillibert-Duplantier J., Marthan R., Savineau J.P., Ducret T. Involvement of TRPV1 and TRPV4 channels in migration of rat pulmonary arterial smooth muscle cells. Pflugers Arch. 2012, 464:261-272.
40. Naylor J., Li J., Milligan C.J., Zeng F., Sukumar P., Hou B., Sedo A., Yuldasheva N., Majeed Y., Beri D., Jiang S., Seymour V.A., McKeown L., Kumar B., Harteneck C., O'Regan D., Wheatcroft S.B., Kearney M.T., Jones C., Porter K.E., Beech D.J. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction. Circ. Res. 2010, 106:1507-1515.
41. Zhang Z., Wang M., Fan X.H., Chen J.H., Guan Y.Y., Tang Y.B. Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta. Circ. Res. 2012, 111:1137-1146.
42. Kaneko Y., Szallasi A. Transient receptor potential (TRP) channels: a clinical perspective. Br. J. Pharmacol. 2014, 171:2474-2507.
43. Inoue R., Jensen L.J., Shi J., Morita H., Nishida M., Honda A., Ito Y. Transient receptor potential channels in cardiovascular function and disease. Circ. Res. 2006, 99:119-131.
44. Sabourin J., Robin E., Raddatz E. A key role of TRPC channels in the regulation of electromechanical activity of the developing heart. Cardiovasc. Res. 2011, 92:226-236.
45. Abriel H., Syam N., Sottas V., Amarouch M.Y., Rougier J.S. TRPM4 channels in the cardiovascular system: physiology, pathophysiology, and pharmacology. Biochem. Pharmacol. 2012, 84:873-881.
46. Kruse M., Schulze-Bahr E., Corfield V., Beckmann A., Stallmeyer B., Kurtbay G., Ohmert I., Brink P., Pongs O. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J. Clin. Invest. 2009, 119:2737-2744.
47. Liu H., El Zein L., Kruse M., Guinamard R., Beckmann A., Bozio A., Kurtbay G., Megarbane A., Ohmert I., Blaysat G., Villain E., Pongs O., Bouvagnet P. Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease. Circ. Cardiovasc. Genet. 2010, 3:374-385.
48. Stallmeyer B., Zumhagen S., Denjoy I., Duthoit G., Hebert J.L., Ferrer X., Maugenre S., Schmitz W., Kirchhefer U., Schulze-Bahr E., Guicheney P. Mutational spectrum in the Ca(2+)-activated cation channel gene TRPM4 in patients with cardiac conductance disturbances. Hum. Mutat. 2012, 33:109-117.
49. Du J., Xie J., Zhang Z., Tsujikawa H., Fusco D., Silverman D., Liang B., Yue L. TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ. Res. 2010, 106:992-1003.
50. Harada M., Luo X., Qi X.Y., Tadevosyan A., Maguy A., Ordog B., Ledoux J., Kato T., Naud P., Voigt N., Shi Y., Kamiya K., Murohara T., Kodama I., Tardif J.C., Schotten U., Van Wagoner D.R., Dobrev D., Nattel S. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 2012, 126:2051-2064.
51. Eder P., Molkentin J.D. TRPC channels as effectors of cardiac hypertrophy. Circ. Res. 2011, 108:265-272.
52. Watanabe H., Murakami M., Ohba T., Takahashi Y., Ito H. TRP channel and cardiovascular disease. Pharmacol. Ther. 2008, 118:337-351.
53. Wu X., Eder P., Chang B., Molkentin J.D. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7000-7005.
54. Seth M., Zhang Z.S., Mao L., Graham V., Burch J., Stiber J., Tsiokas L., Winn M., Abramowitz J., Rockman H.A., Birnbaumer L., Rosenberg P. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ. Res. 2009, 105:1023-1030.
55. Nakayama H., Wilkin B.J., Bodi I., Molkentin J.D. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J. 2006, 20:1660-1670.
56. Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A., Olson E.N. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J. Clin. Invest. 2006, 116:3114-3126.
57. Onohara N., Nishida M., Inoue R., Kobayashi H., Sumimoto H., Sato Y., Mori Y., Nagao T., Kurose H. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 2006, 25:5305-5316.
58. Buckley C.L., Stokes A.J. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy. Channels (Austin) 2011, 5:367-374.
59. Anyatonwu G.I., Estrada M., Tian X., Somlo S., Ehrlich B.E. Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6454-6459.
60. MacDonald P.E., Rorsman P. Oscillations, intercellular coupling, and insulin secretion in pancreatic beta cells. PLoS Biol. 2006, 4:e49.
61. Colsoul B., Vennekens R., Nilius B. Transient receptor potential cation channels in pancreatic beta cells. Rev. Physiol. Biochem. Pharmacol. 2011, 161:87-110.
62. Henquin J.C., Nenquin M., Ravier M.A., Szollosi A. Shortcomings of current models of glucose-induced insulin secretion. Diabetes Obes. Metab. 2009, 11(Suppl. 4):168-179.
63. Jacobson D.A., Philipson L.H. TRP channels of the pancreatic beta cell. Handb. Exp. Pharmacol. 2007, 409-424.
64. Drews G., Krippeit-Drews P., Dufer M. Electrophysiology of islet cells. Adv. Exp. Med. Biol. 2010, 654:115-163.
65. Islam M.S. Calcium signaling in the islets. Adv. Exp. Med. Biol. 2010, 654:235-259.
66. Diaz-Garcia C.M. The TRPA1 channel and oral hypoglycemic agents: is there complicity in beta-cell exhaustion?. Channels (Austin) 2013, 7:420-422.
67. Numazawa S., Takase M., Ahiko T., Ishii M., Shimizu S., Yoshida T. Possible involvement of transient receptor potential channels in electrophile-induced insulin secretion from RINm5F cells. Biol. Pharm. Bull. 2012, 35:346-354.
68. Roe M.W., Worley J.F., Qian F., Tamarina N., Mittal A.A., Dralyuk F., Blair N.T., Mertz R.J., Philipson L.H., Dukes I.D. Characterization of a Ca2+ release-activated nonselective cation current regulating membrane potential and [Ca2+]i oscillations in transgenically derived beta-cells. J. Biol. Chem. 1998, 273:10402-10410.
69. Freichel M., Philipp S., Cavalie A., Flockerzi V. TRPC4 and TRPC4-deficient mice. Novartis Found. Symp. 2004, 258:189-199. (discussion 199-203, 263-186).
70. Park S.H., Ryu S.Y., Yu W.J., Han Y.E., Ji Y.S., Oh K., Sohn J.W., Lim A., Jeon J.P., Lee H., Lee K.H., Lee S.H., Berggren P.O., Jeon J.H., Ho W.K. Leptin promotes K(ATP) channel trafficking by AMPK signaling in pancreatic beta-cells. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:12673-12678.
71. Colsoul B., Schraenen A., Lemaire K., Quintens R., Van Lommel L., Segal A., Owsianik G., Talavera K., Voets T., Margolskee R.F., Kokrashvili Z., Gilon P., Nilius B., Schuit F.C., Vennekens R. Loss of high-frequency glucose-induced Ca2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5-/- mice. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5208-5213.
72. Brixel L.R., Monteilh-Zoller M.K., Ingenbrandt C.S., Fleig A., Penner R., Enklaar T., Zabel B.U., Prawitt D. TRPM5 regulates glucose-stimulated insulin secretion. Pflugers Arch. 2010, 460:69-76.
73. Hofmann T., Chubanov V., Gudermann T., Montell C. TRPM5 is a voltage-modulated and Ca(2+)-activated monovalent selective cation channel. Curr. Biol. 2003, 13:1153-1158.
74. Oike H., Wakamori M., Mori Y., Nakanishi H., Taguchi R., Misaka T., Matsumoto I., Abe K. Arachidonic acid can function as a signaling modulator by activating the TRPM5 cation channel in taste receptor cells. Biochim. Biophys. Acta 2006, 1761:1078-1084.
75. Nakagawa Y., Nagasawa M., Yamada S., Hara A., Mogami H., Nikolaev V.O., Lohse M.J., Shigemura N., Ninomiya Y., Kojima I. Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS One 2009, 4:e5106.
76. Cheng H., Beck A., Launay P., Gross S.A., Stokes A.J., Kinet J.P., Fleig A., Penner R. TRPM4 controls insulin secretion in pancreatic beta-cells. Cell Calcium 2007, 41:51-61.
77. Marigo V., Courville K., Hsu W.H., Feng J.M., Cheng H. TRPM4 impacts on Ca2+ signals during agonist-induced insulin secretion in pancreatic beta-cells. Mol. Cell. Endocrinol. 2009, 299:194-203.
78. Vennekens R., Olausson J., Meissner M., Bloch W., Mathar I., Philipp S.E., Schmitz F., Weissgerber P., Nilius B., Flockerzi V., Freichel M. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat. Immunol. 2007, 8:312-320.
79. Herson P.S., Ashford M.L. Activation of a novel non-selective cation channel by alloxan and H2O2 in the rat insulin-secreting cell line CRI-G1. J. Physiol. 1997, 501(Pt 1):59-66.
80. Togashi K., Hara Y., Tominaga T., Higashi T., Konishi Y., Mori Y., Tominaga M. TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. EMBO J. 2006, 25:1804-1815.
81. Uchida K., Dezaki K., Damdindorj B., Inada H., Shiuchi T., Mori Y., Yada T., Minokoshi Y., Tominaga M. Lack of TRPM2 impaired insulin secretion and glucose metabolisms in mice. Diabetes 2011, 60:119-126.
82. 2+-release channel in beta cells. Sci. Signal. 2009, 2:ra23.
83. Razavi R., Chan Y., Afifiyan F.N., Liu X.J., Wan X., Yantha J., Tsui H., Tang L., Tsai S., Santamaria P., Driver J.P., Serreze D., Salter M.W., Dosch H.M. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 2006, 127:1123-1135.
84. Hisanaga E., Nagasawa M., Ueki K., Kulkarni R.N., Mori M., Kojima I. Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells. Diabetes 2009, 58:174-184.
85. Kottgen M., Buchholz B., Garcia-Gonzalez M.A., Kotsis F., Fu X., Doerken M., Boehlke C., Steffl D., Tauber R., Wegierski T., Nitschke R., Suzuki M., Kramer-Zucker A., Germino G.G., Watnick T., Prenen J., Nilius B., Kuehn E.W., Walz G. TRPP2 and TRPV4 form a polymodal sensory channel complex. J. Cell Biol. 2008, 182:437-447.
86. Grapengiesser E., Gylfe E., Dansk H., Hellman B. Stretch activation of Ca2+ transients in pancreatic beta cells by mobilization of intracellular stores. Pancreas 2003, 26:82-86.
87. Cao D.S., Zhong L., Hsieh T.H., Abooj M., Bishnoi M., Hughes L., Premkumar L.S. Expression of transient receptor potential ankyrin 1 (TRPA1) and its role in insulin release from rat pancreatic beta cells. PLoS One 2012, 7:e38005.
88. Wang P., Fiaschi-Taesch N.M., Vasavada R.C., Scott D.K., Garcia-Ocana A., Stewart A.F. Diabetes mellitus-advances and challenges in human beta-cell proliferation. Nat. Rev. Endocrinol. 2015, 11:201-212.
89. Ashcroft F.M., Rorsman P. Molecular defects in insulin secretion in type-2 diabetes. Rev. Endocr. Metab. Disord. 2004, 5:135-142.
90. Ketterer C., Mussig K., Heni M., Dudziak K., Randrianarisoa E., Wagner R., Machicao F., Stefan N., Holst J.J., Fritsche A., Haring H.U., Staiger H. Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes. Metabolism 2011, 60:1325-1333.
91. McCoy D.D., Zhou L., Nguyen A.K., Watts A.G., Donovan C.M., McKemy D.D. Enhanced insulin clearance in mice lacking TRPM8 channels. Am. J. Physiol. Endocrinol. Metab. 2013, 305:E78-E88.
92. Babes A., Fischer M.J., Filipovic M., Engel M.A., Flonta M.L., Reeh P.W. The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel. Eur. J. Pharmacol. 2013, 704:15-22.
93. Graham S., Yuan J.P., Ma R. Canonical transient receptor potential channels in diabetes. Exp. Biol. Med. (Maywood) 2012, 237:111-118.
94. Chung A.W., Yeung K.Au., Chum E., Okon E.B., van Breemen C. Diabetes modulates capacitative calcium entry and expression of transient receptor potential canonical channels in human saphenous vein. Eur. J. Pharmacol. 2009, 613:114-118.
95. Mita M., Ito K., Taira K., Nakagawa J., Walsh M.P., Shoji M. Attenuation of store-operated Ca2+ entry and enhanced expression of TRPC channels in caudal artery smooth muscle from Type 2 diabetic Goto-Kakizaki rats. Clin. Exp. Pharmacol. Physiol. 2010, 37:670-678.
96. Bishara N.B., Ding H. Glucose enhances expression of TRPC1 and calcium entry in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H171-H178.
97. Sobol A.B., Watala C. The role of platelets in diabetes-related vascular complications. Diabetes Res. Clin. Pract. 2000, 50:1-16.
98. 2+-ATPase function in platelets from patients with non-insulin-dependent diabetes mellitus. Haematologica 2004, 89:1142-1144.
99. src hyperactivity are modulated by hyperglycemia in platelets from patients with non insulin-dependent diabetes mellitus. Arch. Biochem. Biophys. 2004, 432:261-268.
100. Zbidi H., Lopez J.J., Amor N.B., Bartegi A., Salido G.M., Rosado J.A. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cells Mol. Dis. 2009, 43:211-213.
101. Liu D., Maier A., Scholze A., Rauch U., Boltzen U., Zhao Z., Zhu Z., Tepel M. High glucose enhances transient receptor potential channel canonical type 6-dependent calcium influx in human platelets via phosphatidylinositol 3-kinase-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 2008, 28:746-751.
102. Redondo P.C., Jardin I., Hernandez-Cruz J.M., Pariente J.A., Salido G.M., Rosado J.A. Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients. Biochem. Biophys. Res. Commun. 2005, 333:794-802.
103. Liu J., Fitzgerald M.E., Berndt M.C., Jackson C.W., Gartner T.K. Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo. Blood 2006, 108:2596-2603.
104. Redondo P.C., Ben-Amor N., Salido G.M., Bartegi A., Pariente J.A., Rosado J.A. Ca2+-independent activation of Bruton's tyrosine kinase is required for store-mediated Ca2+ entry in human platelets. Cell. Signal. 2005, 17:1011-1021.
105. Bose R., Li Y., Woo V. Sodium-calcium exchange in platelets of diabetics. Proc. West. Pharmacol. Soc. 2001, 44:183-184.
106. Jardin I., Lopez J.J., Zbidi H., Bartegi A., Salido G.M., Rosado J.A. Attenuated store-operated divalent cation entry and association between STIM1, Orai1, hTRPC1 and hTRPC6 in platelets from type 2 diabetic patients. Blood Cells Mol. Dis. 2011, 46:252-260.
107. 2+ channels. J. Biol. Chem. 2008, 283:25296-25304.
108. Jardin I., Salido G.M., Rosado J.A. Role of lipid rafts in the interaction between hTRPC1, Orai1 and STIM1. Channels (Austin) 2008, 2:401-403.
109. Zhang D., Freedman B.I., Flekac M., Santos E., Hicks P.J., Bowden D.W., Efendic S., Brismar K., Gu H.F. Evaluation of genetic association and expression reduction of TRPC1 in the development of diabetic nephropathy. Am. J. Nephrol. 2009, 29:244-251.
110. Niehof M., Borlak J. HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. Diabetes 2008, 57:1069-1077.
111. He F., Peng F., Xia X., Zhao C., Luo Q., Guan W., Li Z., Yu X., Huang F. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 2014, 57:1726-1736.
112. Graham S., Ding M., Sours-Brothers S., Yorio T., Ma J.X., Ma R. Downregulation of TRPC6 protein expression by high glucose, a possible mechanism for the impaired Ca2+ signaling in glomerular mesangial cells in diabetes. Am. J. Physiol. Ren. Physiol. 2007, 293:F1381-F1390.
113. Graham S., Gorin Y., Abboud H.E., Ding M., Lee D.Y., Shi H., Ding Y., Ma R. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am. J. Physiol. Cell Physiol. 2011, 301:C304-C315.
114. Jung J.H., Kim B.J., Chae M.R., Kam S.C., Jeon J.H., So I., Chung K.H., Lee S.W. Gene transfer of TRPC6 (dominant negative) restores erectile function in diabetic rats. J. Sex. Med. 2010, 7:1126-1138.
115. Sung H.H., Choo S.H., Ko M., Kang S.J., Chae M.R., Kam S.C., Han D.H., So I., Lee S.W. Increased expression of TRPC4 channels associated with erectile dysfunction in diabetes. Andrology 2014, 2:550-558.
116. Koivisto A., Hukkanen M., Saarnilehto M., Chapman H., Kuokkanen K., Wei H., Viisanen H., Akerman K.E., Lindstedt K., Pertovaara A. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol. Res. 2012, 65:149-158.
117. Naziroglu M., Dikici D.M., Dursun S. Role of oxidative stress and Ca(2)(+) signaling on molecular pathways of neuropathic pain in diabetes: focus on TRP channels. Neurochem. Res. 2012, 37:2065-2075.
118. Yao X., Kwan H.Y., Huang Y. Regulation of TRP channels by phosphorylation. Neurosignals 2005, 14:273-280.
119. Roderick H.L., Cook S.J. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 2008, 8:361-375.
120. Pedersen S.F., Owsianik G., Nilius B. TRP channels: an overview. Cell Calcium 2005, 38:233-252.
121. Monteith G.R., McAndrew D., Faddy H.M., Roberts-Thomson S.J. Calcium and cancer: targeting Ca2+ transport. Nat. Rev. Cancer 2007, 7:519-530.
122. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
123. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nature reviews. Mol. Cell. Biol. 2003, 4:552-565.
124. Pinton P., Giorgi C., Siviero R., Zecchini E., Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 2008, 27:6407-6418.
125. Prevarskaya N., Skryma R., Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol. Med. 2010, 16:107-121.
126. Cook S.J., Lockyer P.J. Recent advances in Ca(2+)-dependent Ras regulation and cell proliferation. Cell Calcium 2006, 39:101-112.
127. Whitfield J.F. Calcium signals and cancer. Crit. Rev. Oncog. 1992, 3:55-90.
128. Hoyer-Hansen M., Jaattela M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007, 14:1576-1582.
129. Johnson J.D., Han Z., Otani K., Ye H., Zhang Y., Wu H., Horikawa Y., Misler S., Bell G.I., Polonsky K.S. RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. J. Biol. Chem. 2004, 279:24794-24802.
130. Leanza L., Biasutto L., Manago A., Gulbins E., Zoratti M., Szabo I. Intracellular ion channels and cancer. Front. Physiol. 2013, 4:227.
131. Zeng X., Sikka S.C., Huang L., Sun C., Xu C., Jia D., Abdel-Mageed A.B., Pottle J.E., Taylor J.T., Li M. Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis. 2010, 13:195-201.
132. Bidaux G., Beck B., Zholos A., Gordienko D., Lemonnier L., Flourakis M., Roudbaraki M., Borowiec A.S., Fernandez J., Delcourt P., Lepage G., Shuba Y., Skryma R., Prevarskaya N. Regulation of activity of transient receptor potential melastatin 8 (TRPM8) channel by its short isoforms. J. Biol. Chem. 2012, 287:2948-2962.
133. Yamauchi T. Neuronal Ca2+/calmodulin-dependent protein kinase II-discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol. Pharm. Bull. 2005, 28:1342-1354.
134. McGargill M.A., Sharp L.L., Bui J.D., Hedrick S.M., Calbo S. Active Ca2+/calmodulin-dependent protein kinase II gamma B impairs positive selection of T cells by modulating TCR signaling. J. Immunol. 2005, 175:656-664.
135. Lin M.Y., Zal T., Ch'en I.L., Gascoigne N.R., Hedrick S.M. A pivotal role for the multifunctional calcium/calmodulin-dependent protein kinase II in T cells: from activation to unresponsiveness. J. Immunol. 2005, 174:5583-5592.
136. Chandel N.S., Trzyna W.C., McClintock D.S., Schumacker P.T. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J. Immunol. 2000, 165:1013-1021.
137. Renard P., Zachary M.D., Bougelet C., Mirault M.E., Haegeman G., Remacle J., Raes M. Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation. Biochem. Pharmacol. 1997, 53:149-160.
138. Wu H.Y., Tomizawa K., Matsui H. Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder. Acta Med. Okayama 2007, 61:123-137.
139. Heit J.J., Apelqvist A.A., Gu X., Winslow M.M., Neilson J.R., Crabtree G.R., Kim S.K. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006, 443:345-349.
140. Premkumar L.S., Abooj M. TRP channels and analgesia. Life Sci. 2013, 92:415-424.
141. Yue L., Peng J.B., Hediger M.A., Clapham D.E. CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature 2001, 410:705-709.
142. Bodding M., Flockerzi V. Ca2+ dependence of the Ca2+-selective TRPV6 channel. J. Biol. Chem. 2004, 279:36546-36552.
143. Bolanz K.A., Hediger M.A., Landowski C.P. The role of TRPV6 in breast carcinogenesis. Mol. Cancer Ther. 2008, 7:271-279.
144. Wissenbach U., Niemeyer B.A., Fixemer T., Schneidewind A., Trost C., Cavalie A., Reus K., Meese E., Bonkhoff H., Flockerzi V. Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J. Biol. Chem. 2001, 276:19461-19468.
145. Peng J.B., Zhuang L., Berger U.V., Adam R.M., Williams B.J., Brown E.M., Hediger M.A., Freeman M.R. CaT1 expression correlates with tumor grade in prostate cancer. Biochem. Biophys. Res. Commun. 2001, 282:729-734.
146. Vanden Abeele F., Roudbaraki M., Shuba Y., Skryma R., Prevarskaya N. Store-operated Ca2+ current in prostate cancer epithelial cells. Role of endogenous Ca2+ transporter type 1. J. Biol. Chem. 2003, 278:15381-15389.
147. Zhuang L., Peng J.B., Tou L., Takanaga H., Adam R.M., Hediger M.A., Freeman M.R. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab. Investig. 2002, 82:1755-1764.
148. Fixemer T., Wissenbach U., Flockerzi V., Bonkhoff H. Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 2003, 22:7858-7861.
149. Peters A.A., Simpson P.T., Bassett J.J., Lee J.M., Da Silva L., Reid L.E., Song S., Parat M.O., Lakhani S.R., Kenny P.A., Roberts-Thomson S.J., Monteith G.R. Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer. Mol. Cancer Ther. 2012, 11:2158-2168.
150. Bodding M., Fecher-Trost C., Flockerzi V. Store-operated Ca2+ current and TRPV6 channels in lymph node prostate cancer cells. J. Biol. Chem. 2003, 278:50872-50879.
151. Raphael M., Lehen'kyi V., Vandenberghe M., Beck B., Khalimonchyk S., Vanden Abeele F., Farsetti L., Germain E., Bokhobza A., Mihalache A., Gosset P., Romanin C., Clezardin P., Skryma R., Prevarskaya N. TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E3870-E3879.
152. Monet M., Lehen'kyi V., Gackiere F., Firlej V., Vandenberghe M., Roudbaraki M., Gkika D., Pourtier A., Bidaux G., Slomianny C., Delcourt P., Rassendren F., Bergerat J.P., Ceraline J., Cabon F., Humez S., Prevarskaya N. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res. 2010, 70:1225-1235.
153. Nabissi M., Morelli M.B., Santoni M., Santoni G. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 2013, 34:48-57.
154. Fan H., Shen Y.X., Yuan Y.F. Expression and prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer after curative resection. Asian Pac. J. Cancer Prev. 2014, 15:2559-2563.
155. Ariano P., Dalmazzo S., Owsianik G., Nilius B., Lovisolo D. TRPC channels are involved in calcium-dependent migration and proliferation in immortalized GnRH neurons. Cell Calcium 2011, 49:387-394.
156. Fabian A., Fortmann T., Bulk E., Bomben V.C., Sontheimer H., Schwab A. Chemotaxis of MDCK-F cells toward fibroblast growth factor-2 depends on transient receptor potential canonical channel 1. Pflugers Arch. - Eur. J. Physiol. 2011, 461:295-306.
157. Fabian A., Fortmann T., Dieterich P., Riethmuller C., Schon P., Mally S., Nilius B., Schwab A. TRPC1 channels regulate directionality of migrating cells. Pflugers Arch. - Eur. J. Physiol. 2008, 457:475-484.
158. Zanou N., Shapovalov G., Louis M., Tajeddine N., Gallo C., Van Schoor M., Anguish I., Cao M.L., Schakman O., Dietrich A., Lebacq J., Ruegg U., Roulet E., Birnbaumer L., Gailly P. Role of TRPC1 channel in skeletal muscle function. Am. J. Physiol. Cell Physiol. 2010, 298:C149-C162.
159. He B., Liu F., Ruan J., Li A., Chen J., Li R., Shen J., Zheng D., Luo R. Silencing TRPC1 expression inhibits invasion of CNE2 nasopharyngeal tumor cells. Oncol. Rep. 2012, 27:1548-1554.
160. Tajeddine N., Gailly P. TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling. J. Biol. Chem. 2012, 287:16146-16157.
161. Bomben V.C., Turner K.L., Barclay T.T., Sontheimer H. Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas. J. Cell. Physiol. 2011, 226:1879-1888.
162. Bon R.S., Beech D.J. In pursuit of small molecule chemistry for calcium-permeable non-selective TRPC channels - mirage or pot of gold?. Br. J. Pharmacol. 2013, 170:459-474.
163. Cai R., Ren G., Ding X., Wang Y.Z., Jin Y.N. Essential role of TRPC6 in the proliferation of gastric cancer and its mechanism. Zhonghua Zhong Liu Za Zhi 2012, 34:577-581.
164. Thebault S., Flourakis M., Vanoverberghe K., Vandermoere F., Roudbaraki M., Lehen'kyi V., Slomianny C., Beck B., Mariot P., Bonnal J.L., Mauroy B., Shuba Y., Capiod T., Skryma R., Prevarskaya N. Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res. 2006, 66:2038-2047.
165. El Boustany C., Bidaux G., Enfissi A., Delcourt P., Prevarskaya N., Capiod T. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 2008, 47:2068-2077.
166. Ma X., Cai Y., He D., Zou C., Zhang P., Lo C.Y., Xu Z., Chan F.L., Yu S., Chen Y., Zhu R., Lei J., Jin J., Yao X. Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:16282-16287.
167. Aydar E., Yeo S., Djamgoz M., Palmer C. Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy. Cancer Cell Int. 2009, 9:23.
168. Guilbert A., Dhennin-Duthille I., Hiani Y.E., Haren N., Khorsi H., Sevestre H., Ahidouch A., Ouadid-Ahidouch H. Expression of TRPC6 channels in human epithelial breast cancer cells. BMC Cancer 2008, 8:125.
169. Dhennin-Duthille I., Gautier M., Faouzi M., Guilbert A., Brevet M., Vaudry D., Ahidouch A., Sevestre H., Ouadid-Ahidouch H. High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell. Physiol. Biochem. 2011, 28:813-822.
170. Prawitt D., Enklaar T., Klemm G., Gartner B., Spangenberg C., Winterpacht A., Higgins M., Pelletier J., Zabel B. Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression. Hum. Mol. Genet. 2000, 9:203-216.
171. Suguro M., Tagawa H., Kagami Y., Okamoto M., Ohshima K., Shiku H., Morishima Y., Nakamura S., Seto M. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature. Cancer Sci. 2006, 97:868-874.
172. Singh J., Manickam P., Shmoish M., Natik S., Denyer G., Handelsman D., Gong D.W., Dong Q. Annotation of androgen dependence to human prostate cancer-associated genes by microarray analysis of mouse prostate. Cancer Lett. 2006, 237:298-304.
173. Schinke E.N., Bii V., Nalla A., Rae D.T., Tedrick L., Meadows G.G., Trobridge G.D. A novel approach to identify driver genes involved in androgen-independent prostate cancer. Mol. Cancer 2014, 13:120.
174. Armisen R., Marcelain K., Simon F., Tapia J.C., Toro J., Quest A.F., Stutzin A. TRPM4 enhances cell proliferation through up-regulation of the beta-catenin signaling pathway. J. Cell. Physiol. 2011, 226:103-109.
175. Guilbert A., Gautier M., Dhennin-Duthille I., Haren N., Sevestre H., Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am. J. Physiol. Cell Physiol. 2009, 297:C493-C502.
176. Kim B.J. Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J. Ginseng Res. 2013, 37:201-209.
177. Rybarczyk P., Gautier M., Hague F., Dhennin-Duthille I., Chatelain D., Kerr-Conte J., Pattou F., Regimbeau J.M., Sevestre H., Ouadid-Ahidouch H. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int. J. Cancer 2012, 131:E851-E861.
178. Yee N.S., Kazi A.A., Li Q., Yang Z., Berg A., Yee R.K. Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: required for cancer cell invasion and implicated in tumor growth and metastasis. Biol. Open 2015, 4:507-514.
179. Dou Y., Li Y., Chen J., Wu S., Xiao X., Xie S., Tang L., Yan M., Wang Y., Lin J., Zhu W., Yan G. Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7. Oncol. Lett. 2013, 5:1010-1016.
180. Chen J.P., Wang J., Luan Y., Wang C.X., Li W.H., Zhang J.B., Sha D., Shen R., Cui Y.G., Zhang Z., Zhang L.M., Wang W.B. TRPM7 promotes the metastatic process in human nasopharyngeal carcinoma. Cancer Lett. 2015, 356:483-490.
181. Sun Y., Selvaraj S., Varma A., Derry S., Sahmoun A.E., Singh B.B. Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels. J. Biol. Chem. 2013, 288:255-263.
182. Visser D., Langeslag M., Kedziora K.M., Klarenbeek J., Kamermans A., Horgen F.D., Fleig A., van Leeuwen F.N., Jalink K. TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cells. Cell Calcium 2013, 54:404-415.
183. Lange I., Koomoa D.L. MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines. FEBS Open Bio 2014, 4:966-975.
184. Middelbeek J., Visser D., Henneman L., Kamermans A., Kuipers A.J., Hoogerbrugge P.M., Jalink K., van Leeuwen F.N. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation. Oncotarget 2015, 6:8760-8776.
185. Pigozzi D., Ducret T., Tajeddine N., Gala J.L., Tombal B., Gailly P. Calcium store contents control the expression of TRPC1, TRPC3 and TRPV6 proteins in LNCaP prostate cancer cell line. Cell Calcium 2006, 39:401-415.
186. Misra U.K., Mowery Y.M., Gawdi G., Pizzo S.V. Loss of cell surface TFII-I promotes apoptosis in prostate cancer cells stimulated with activated alpha(2) -macroglobulin. J. Cell. Biochem. 2011, 112:1685-1695.
187. Zhang H., Zhou L., Shi W., Song N., Yu K., Gu Y. A mechanism underlying the effects of polyunsaturated fatty acids on breast cancer. Int. J. Mol. Med. 2012, 30:487-494.
188. Tao X., Zhao N., Jin H., Zhang Z., Liu Y., Wu J., Bast R.C., Yu Y., Feng Y. FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3. Endocr. Relat. Cancer 2013, 20:415-429.
189. Deeds J., Cronin F., Duncan L.M. Patterns of melastatin mRNA expression in melanocytic tumors. Hum. Pathol. 2000, 31:1346-1356.
190. Duncan L.M., Deeds J., Hunter J., Shao J., Holmgren L.M., Woolf E.A., Tepper R.I., Shyjan A.W. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 1998, 58:1515-1520.
191. Lazzeri M., Vannucchi M.G., Spinelli M., Bizzoco E., Beneforti P., Turini D., Faussone-Pellegrini M.S. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. Eur. Urol. 2005, 48:691-698.
192. Sanchez M.G., Sanchez A.M., Collado B., Malagarie-Cazenave S., Olea N., Carmena M.J., Prieto J.C., Diaz-Laviada I.I. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur. J. Pharmacol. 2005, 515:20-27.
193. Ziglioli F., Frattini A., Maestroni U., Dinale F., Ciufifeda M., Cortellini P. Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism. Acta Biomed. 2009, 80:13-20.
194. Sung B., Prasad S., Ravindran J., Yadav V.R., Aggarwal B.B. Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors. Free Radic. Biol. Med. 2012, 53:1977-1987.
195. Shen Y., Rampino M.A., Carroll R.C., Nawy S. G-protein-mediated inhibition of the Trp channel TRPM1 requires the Gbetagamma dimer. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:8752-8757.
196. Fleig A., Penner R. The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol. Sci. 2004, 25:633-639.
197. Duncan L.M., Deeds J., Cronin F.E., Donovan M., Sober A.J., Kauffman M., McCarthy J.J. Melastatin expression and prognosis in cutaneous malignant melanoma. J. Clin. Oncol. 2001, 19:568-576.
198. Fang D., Setaluri V. Expression and Up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells. Biochem. Biophys. Res. Commun. 2000, 279:53-61.
199. Bodding M. TRP proteins and cancer. Cell. Signal. 2007, 19:617-624.
200. Miller A.J., Du J., Rowan S., Hershey C.L., Widlund H.R., Fisher D.E. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res. 2004, 64:509-516.
201. Erickson L.A., Letts G.A., Shah S.M., Shackelton J.B., Duncan L.M. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas. Mod. Pathol. 2009, 22:969-976.
202. Guo H., Carlson J.A., Slominski A. Role of TRPM in melanocytes and melanoma. Exp. Dermatol. 2012, 21:650-654.
203. Xia B., Yang S., Liu T., Lou G. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Mol. Cancer 2015, 14:322.
204. Lis A., Wissenbach U., Philipp S.E. Transcriptional regulation and processing increase the functional variability of TRPM channels. Naunyn Schmiedeberg's Arch. Pharmacol. 2005, 371:315-324.
205. Xu X.Z., Moebius F., Gill D.L., Montell C. Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10692-10697.
206. Zhang W., Hirschler-Laszkiewicz I., Tong Q., Conrad K., Sun S.C., Penn L., Barber D.L., Stahl R., Carey D.J., Cheung J.Y., Miller B.A. TRPM2 is an ion channel that modulates hematopoietic cell death through activation of caspases and PARP cleavage. Am. J. Physiol. Cell Physiol. 2006, 290:C1146-C1159.
207. Hara Y., Wakamori M., Ishii M., Maeno E., Nishida M., Yoshida T., Yamada H., Shimizu S., Mori E., Kudoh J., Shimizu N., Kurose H., Okada Y., Imoto K., Mori Y. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 2002, 9:163-173.
208. Cao Q.F., Qian S.B., Wang N., Zhang L., Wang W.M., Shen H.B. TRPM2 Mediates Histone Deacetylase Inhibition-Induced Apoptosis in Bladder Cancer Cells. Cancer Biother. Radiopharm. 2015, 30:87-93.
209. Zhang W., Chu X., Tong Q., Cheung J.Y., Conrad K., Masker K., Miller B.A. A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. J. Biol. Chem. 2003, 278:16222-16229.
210. Middelbeek J., Kuipers A.J., Henneman L., Visser D., Eidhof I., van Horssen R., Wieringa B., Canisius S.V., Zwart W., Wessels L.F., Sweep F.C., Bult P., Span P.N., van Leeuwen F.N., Jalink K. TRPM7 is required for breast tumor cell metastasis. Cancer Res. 2012, 72:4250-4261.
211. Meng X., Cai C., Wu J., Cai S., Ye C., Chen H., Yang Z., Zeng H., Shen Q., Zou F. TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway. Cancer Lett. 2013, 333:96-102.
212. Guilbert A., Gautier M., Dhennin-Duthille I., Rybarczyk P., Sahni J., Sevestre H., Scharenberg A.M., Ouadid-Ahidouch H. Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain. Eur. J. Cancer 2013, 49:3694-3707.
213. Yu H., Zhang Z., Lis A., Penner R., Fleig A. TRPM7 is regulated by halides through its kinase domain. Cell. Mol. Life Sci. 2013, 70:2757-2771.
214. Davis F.M., Azimi I., Faville R.A., Peters A.A., Jalink K., Putney J.W., Goodhill G.J., Thompson E.W., Roberts-Thomson S.J., Monteith G.R. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene 2014, 33:2307-2316.
215. Tsavaler L., Shapero M.H., Morkowski S., Laus R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res. 2001, 61:3760-3769.
216. Bidaux G., Roudbaraki M., Merle C., Crepin A., Delcourt P., Slomianny C., Thebault S., Bonnal J.L., Benahmed M., Cabon F., Mauroy B., Prevarskaya N. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocr. Relat. Cancer 2005, 12:367-382.
217. Zhang L., Barritt G.J. Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Res. 2004, 64:8365-8373.
218. Okamoto Y., Ohkubo T., Ikebe T., Yamazaki J. Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines. Int. J. Oncol. 2012, 40:1431-1440.
219. Cucu D., Chiritoiu G., Petrescu S., Babes A., Stanica L., Duda D.G., Horii A., Dima S.O., Popescu I. Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarcinoma cells. Pancreas 2014, 43:795-800.
220. Du G.J., Li J.H., Liu W.J., Liu Y.H., Zhao B., Li H.R., Hou X.D., Li H., Qi X.X., Duan Y.J. The combination of TRPM8 and TRPA1 expression causes an invasive phenotype in lung cancer. Tumour Biol. 2014, 35:1251-1261.
221. Yang Z.H., Wang X.H., Wang H.P., Hu L.Q. Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells. Asian J. Androl. 2009, 11:157-165.
222. Gkika D., Lemonnier L., Shapovalov G., Gordienko D., Poux C., Bernardini M., Bokhobza A., Bidaux G., Degerny C., Verreman K., Guarmit B., Benahmed M., de Launoit Y., Bindels R.J., Fiorio Pla A., Prevarskaya N. TRP channel-associated factors are a novel protein family that regulates TRPM8 trafficking and activity. J. Cell Biol. 2015, 208:89-107.
223. Monet M., Gkika D., Lehen'kyi V., Pourtier A., Vanden Abeele F., Bidaux G., Juvin V., Rassendren F., Humez S., Prevarsakaya N. Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim. Biophys. Acta 2009, 1793:528-539.